• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Hypertension Control in Pregnancy

Poll

Which of the following statements regarding the treatment of hypertension in pregnancy are true?

A. With preeclampsia and severe hypertension pre-delivery, parenteral nifedipine, labetalol, or hydralazine may be used.
B. ACE inhibitor use during pregnancy has been associated with oligohydramnios, fetal renal dysfunction, and fetal death.
C. Labetalol may aggravate bradycardia and/or asthma.
Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
FDA Accepts GSK’s Submission for Use of Mepolizumab in COPD

FDA Accepts GSK’s Submission for Use of Mepolizumab in COPD

Sydney Jennings
December 9th 2024
Article

The Prescription Drug User Fee Act date is set for May 7, 2025.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Influenza Antiviral Treatment Underutilized Among Vulnerable Youth: Daily Dose / image credit: ©New Africa/AdobeStock

Influenza Antiviral Treatment Underutilized Among Vulnerable Youth: Daily Dose

Sydney Jennings
December 6th 2024
Article

Your daily dose of the clinical news you may have missed.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Sydney Jennings
October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Fremanezumab Safe and Effective for Prevention of Episodic Migraine in Children: Phase 3 Data Announced / image credit courtesy of Vall d'Hebron

Fremanezumab Safe and Effective for Prevention of Episodic Migraine in Children: Phase 3 Data Announced

Grace Halsey
December 5th 2024
Article

The CGRP inhibitor fremanezumab reduced both monthly migraine and monthly headache days among children aged 6 to 17 years with a favorable safety profile.

Exercise of Any Level Cuts Mortality Risk in People with Dementia: Daily Dose / image credit: ©New Africa/AdobeStock

Exercise of Any Level Cuts Mortality Risk in People with Dementia: Daily Dose

Sydney Jennings
December 5th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.